| J9271 | Injection, pembrolizumab, 1 mg | 14,200 | $40 | $596.4K |
| J9299 | Injection, nivolumab, 1 mg | 21,680 | $20 | $520.3K |
| J0897 | Injection, denosumab, 1 mg | 4,800 | $20 | $91.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,300 | $60 | $76.6K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 4,200 | $20 | $67.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 730 | $90 | $65.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 690 | $90 | $61.9K |
| Q5122 | Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | 360 | $90 | $33.5K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 180 | $150 | $28K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 390 | $60 | $23.6K |